Scott A. Holmes
2016 - Keryx Biopharmaceuticals
In 2016, Scott A. Holmes earned a total compensation of $926.3K as Chief Financial Officer and Treasurer at Keryx Biopharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $6,000 |
|---|---|
| Non-Equity Incentive Plan | $122,570 |
| Option Awards | $251,765 |
| Salary | $359,371 |
| Stock Awards | $180,063 |
| Other | $6,526 |
| Total | $926,295 |
Holmes received $359.4K in salary, accounting for 39% of the total pay in 2016.
Holmes also received $6K in bonus, $122.6K in non-equity incentive plan, $251.8K in option awards, $180.1K in stock awards and $6.5K in other compensation.
Rankings
In 2016, Scott A. Holmes' compensation ranked 8,602nd out of 14,075 executives tracked by ExecPay. In other words, Holmes earned more than 38.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,602 out of 14,075 | 39th |
Division Manufacturing | 3,312 out of 5,486 | 40th |
Major group Chemicals And Allied Products | 1,120 out of 1,900 | 41st |
Industry group Drugs | 877 out of 1,543 | 43rd |
Industry Pharmaceutical Preparations | 695 out of 1,173 | 41st |
Source: SEC filing on April 26, 2017.
Holmes' colleagues
We found three more compensation records of executives who worked with Scott A. Holmes at Keryx Biopharmaceuticals in 2016.